Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TECHBONE-MAX is a multi-ingredient nutritional supplement developed by Varmed Pharma Private Limited. It is formulated as a softgel capsule containing calcium carbonate, calcitriol (the active form of vitamin D3), methylcobalamin (vitamin B12), folic acid, boron, and omega-3 fatty acids (including EPA and DHA). The supplement is primarily indicated for the management of bone health conditions such as osteopenia and osteoporosis, as well as for addressing nutritional deficiencies. Its mechanism of action involves providing elemental calcium for bone mineralization, enhancing intestinal calcium absorption via calcitriol's action on the Vitamin D receptor, supporting nerve health and cellular function through B-vitamin replacement, and providing anti-inflammatory benefits via omega-3 fatty acids. It is marketed in India as an approved formulation for bone-related disorders and overall well-being.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TECHBONE-MAX.